Bray M - Search Results

1

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

Vanderzanden L, Bray M, Fuller D, Roberts T, Custer D, Spik K, Jahrling P, Huggins J, Schmaljohn A, Schmaljohn C. Vanderzanden L, et al. Among authors: bray m. Virology. 1998 Jun 20;246(1):134-44. doi: 10.1006/viro.1998.9176. Virology. 1998. PMID: 9657001 Free article.

2

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Rao M, Bray M, Alving CR, Jahrling P, Matyas GR. Rao M, et al. Among authors: bray m. J Virol. 2002 Sep;76(18):9176-85. doi: 10.1128/jvi.76.18.9176-9185.2002. J Virol. 2002. PMID: 12186901 Free PMC article.

3

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C. Riemenschneider J, et al. Among authors: bray m. Vaccine. 2003 Sep 8;21(25-26):4071-80. doi: 10.1016/s0264-410x(03)00362-1. Vaccine. 2003. PMID: 12922144

4

Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.

Schmaljohn C, Vanderzanden L, Bray M, Custer D, Meyer B, Li D, Rossi C, Fuller D, Fuller J, Haynes J, Huggins J. Schmaljohn C, et al. Among authors: bray m. J Virol. 1997 Dec;71(12):9563-9. doi: 10.1128/JVI.71.12.9563-9569.1997. J Virol. 1997. PMID: 9371620 Free PMC article.

5

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. Bray M, et al. J Infect Dis. 1998 Sep;178(3):651-61. doi: 10.1086/515386. J Infect Dis. 1998. PMID: 9728532

6

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.

Huggins J, Zhang ZX, Bray M. Huggins J, et al. Among authors: bray m. J Infect Dis. 1999 Feb;179 Suppl 1:S240-7. doi: 10.1086/514316. J Infect Dis. 1999. PMID: 9988190

7

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. Bray M, et al. J Infect Dis. 1999 Feb;179 Suppl 1:S248-58. doi: 10.1086/514292. J Infect Dis. 1999. PMID: 9988191

8

Evaluation of tick-borne encephalitis DNA vaccines in monkeys.

Schmaljohn C, Custer D, VanderZanden L, Spik K, Rossi C, Bray M. Schmaljohn C, et al. Among authors: bray m. Virology. 1999 Oct 10;263(1):166-74. doi: 10.1006/viro.1999.9918. Virology. 1999. PMID: 10544091 Free article.

9

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.

Bray M, Driscoll J, Huggins JW. Bray M, et al. Antiviral Res. 2000 Feb;45(2):135-47. doi: 10.1016/s0166-3542(00)00066-8. Antiviral Res. 2000. PMID: 10809022

10

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF. Pushko P, et al. Among authors: bray m. Vaccine. 2000 Aug 15;19(1):142-53. doi: 10.1016/s0264-410x(00)00113-4. Vaccine. 2000. PMID: 10924796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters